Citigroup’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.7M Buy
53,894
+50,757
+1,618% +$2.88M ﹤0.01% 2403
2026
Q1
$201K Buy
3,137
+2,571
+454% +$234K ﹤0.01% 4003
2025
Q4
$73.6K Sell
566
-2,365
-81% -$325K ﹤0.01% 4445
2025
Q3
$316K Sell
2,931
-5,275
-64% -$575K ﹤0.01% 3789
2025
Q2
$757K Sell
8,206
-8,825
-52% -$693K ﹤0.01% 3355
2025
Q1
$1.51M Buy
17,031
+6,271
+58% +$544K ﹤0.01% 2959
2024
Q4
$827K Buy
10,760
+1,639
+18% +$114K ﹤0.01% 3504
2024
Q3
$387K Buy
9,121
+6,401
+235% +$216K ﹤0.01% 3892
2024
Q2
$71.1K Sell
2,720
-27,039
-91% -$512K ﹤0.01% 4389
2024
Q1
$272K Buy
29,759
+29,757
+1,487,850% +$179K ﹤0.01% 3881
2023
Q4
$7 Sell
2
-50
-96% -$116 ﹤0.01% 5645
2023
Q3
$191 Sell
52
-16
-24% -$88 ﹤0.01% 5325
2023
Q2
$408 Buy
68
+52
+325% +$412 ﹤0.01% 5390
2023
Q1
$195 Sell
16
-114
-88% -$1.52K ﹤0.01% 5259
2022
Q4
$1.14K Sell
130
-966
-88% -$21.3K ﹤0.01% 5376
2022
Q3
$32K Sell
1,096
-258
-19% -$11.8K ﹤0.01% 4574
2022
Q2
$56K Sell
1,354
-965
-42% -$65.5K ﹤0.01% 4491
2022
Q1
$235K Buy
2,319
+764
+49% +$84.9K ﹤0.01% 3997
2021
Q4
$229K Buy
1,555
+1,238
+391% +$277K ﹤0.01% 4286
2021
Q3
$79K Buy
+317
New +$109K ﹤0.01% 4505

Other funds holding WGS

Citigroup's WGS Position: Q2 2026 in Review

Citigroup increased its GeneDx Holdings (WGS) stake by 1,618% in Q2 2026, buying an estimated $2.88M and bringing the position to 53,894 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2403.

Citigroup first reported a position in WGS in Q3 2021 and has held it in 20 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Citigroup held 53,894 shares of GeneDx Holdings worth $3.7M as of Q2 2026.
  • Citigroup bought 50,757 GeneDx Holdings shares in Q2 2026, an estimated $2.88M.
  • GeneDx Holdings made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2403 holding.
  • Citigroup first reported a position in GeneDx Holdings in Q3 2021 and has held it in 20 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.